Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1976 1
1978 1
1979 2
1983 1
1986 1
1989 3
1991 1
1992 4
1993 2
1994 2
1995 1
1996 2
1997 2
1998 1
1999 3
2000 1
2001 1
2002 6
2003 12
2004 15
2005 20
2006 33
2007 31
2008 42
2009 29
2010 20
2011 21
2012 18
2013 22
2014 26
2015 45
2016 73
2017 84
2018 71
2019 51
2020 62
2021 54
2022 54
2023 19
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 14964744

707 results

Results by year

Filters applied: . Clear all
Page 1
Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
Woolacott N, Hawkins N, Mason A, Kainth A, Khadjesari Z, Vergel YB, Misso K, Light K, Chalmers R, Sculpher M, Riemsma R. Woolacott N, et al. Health Technol Assess. 2006 Nov;10(46):1-233, i-iv. doi: 10.3310/hta10460. Health Technol Assess. 2006. PMID: 17083854 Free article. Review.
CLinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial.
Dubertret L, Sterry W, Bos JD, Chimenti S, Shumack S, Larsen CG, Shear NH, Papp KA; CLEAR Multinational Study Group. Dubertret L, et al. Br J Dermatol. 2006 Jul;155(1):170-81. doi: 10.1111/j.1365-2133.2006.07344.x. Br J Dermatol. 2006. PMID: 16792770 Clinical Trial.
707 results